Details for New Drug Application (NDA): 204982
✉ Email this page to a colleague
The generic ingredient in PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE is phentermine hydrochloride; topiramate. There are seventeen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the phentermine hydrochloride; topiramate profile page.
Summary for 204982
Tradename: | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE |
Applicant: | Actavis Labs Fl Inc |
Ingredient: | phentermine hydrochloride; topiramate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | EQ 3.75MG BASE;23MG | ||||
Approval Date: | Jun 25, 2024 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | EQ 7.5MG BASE;46MG | ||||
Approval Date: | Jun 25, 2024 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | EQ 11.25MG BASE;69MG | ||||
Approval Date: | Jun 25, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription